Pharmadrug Inc.

LMLLF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$873-$13,262-$3,064-$5,874
Dep. & Amort.$50$26$21$1,283
Deferred Tax$0-$1,010-$190-$834
Stock-Based Comp.$47$1,741$345$600
Change in WC-$303-$58$687-$132
Other Non-Cash$322$11,891-$56$831
Operating Cash Flow-$757-$672-$2,257-$4,125
Investing Activities
PP&E Inv.-$12$0$0-$43
Net Acquisitions$0$742-$12$309
Inv. Purchases$0$0$0$43
Inv. Sales/Matur.$0$0$94$1,214
Other Inv. Act.$0$253-$4-$43
Investing Cash Flow-$12$995$78$1,481
Financing Activities
Debt Repay.$0$4$602$0
Stock Issued$326$300$280$954
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$4$222-$39$777
Financing Cash Flow$322$226$843$777
Forex Effect-$2$3$387$691
Net Chg. in Cash-$449$552-$949-$1,177
Supplemental Information
Beg. Cash$560$9$958$2,135
End Cash$111$560$9$958
Free Cash Flow-$769-$672-$2,257-$4,168